Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar;46(3):279-86.
doi: 10.1038/ng.2878. Epub 2014 Jan 26.

Evolution and transmission of drug-resistant tuberculosis in a Russian population

Affiliations

Evolution and transmission of drug-resistant tuberculosis in a Russian population

Nicola Casali et al. Nat Genet. 2014 Mar.

Abstract

The molecular mechanisms determining the transmissibility and prevalence of drug-resistant tuberculosis in a population were investigated through whole-genome sequencing of 1,000 prospectively obtained patient isolates from Russia. Two-thirds belonged to the Beijing lineage, which was dominated by two homogeneous clades. Multidrug-resistant (MDR) genotypes were found in 48% of isolates overall and in 87% of the major clades. The most common rpoB mutation was associated with fitness-compensatory mutations in rpoA or rpoC, and a new intragenic compensatory substitution was identified. The proportion of MDR cases with extensively drug-resistant (XDR) tuberculosis was 16% overall, with 65% of MDR isolates harboring eis mutations, selected by kanamycin therapy, which may drive the expansion of strains with enhanced virulence. The combination of drug resistance and compensatory mutations displayed by the major clades confers clinical resistance without compromising fitness and transmissibility, showing that, in addition to weaknesses in the tuberculosis control program, biological factors drive the persistence and spread of MDR and XDR tuberculosis in Russia and beyond.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Coverage of the tuberculosis patient population
The location of Samara Oblast in Russia (red) and the Baltic States (Lithuania (Li), Latvia (Lv) and Estonia (E)) are shown in (a). The number of sequenced patient-isolates from each territory (green) and city (blue; Samara City (Sm), Togliatti (T) and Syzran (Sz)) of Samara Oblast (b) or district of Samara City (c) are shown inside circles. The area of each circle reflects coverage of the region (the number of isolates sequenced relative to the number of tuberculosis cases notified).
Figure 2
Figure 2. Maximum likelihood phylogeny of 1,035 M. tuberculosis isolates based on 32,445 variable sites
The four M. tuberculosis lineages: Beijing, CAS, EuroAmerican and EAI, are indicated. The EuroAmerican SNP-defined sublineages and the major Beijing clades are shaded. The ancestral node of the Beijing East European sublineage is indicated with a star. Radial dotted lines show the positions of isolates from the UK; those with an XDR phenotype are marked with white circles. The Estonian strain is indicated by a filled blue circle. The position of the reference sequence, H37Rv, is marked ‘R’. The East European sublineage, Clade A and Clade B had 100% bootstrap support (Supplementary Data 1).
Figure 3
Figure 3. Phylogenetic distribution of drug resistance and compensatory genotypes
The phylogeny of 1,000 Russian isolates is depicted on the left; lineages are colored as Figure 2. The first 16 columns depict drug resistance loci. ‘P’ denotes a promoter region. Within the 16S rRNA gene, rrsstr refers to the 530 stem-loop and 915 regions involved in streptomycin resistance and rrsinj to downstream regions associated with resistance to the second-line injectables. Colored bands represent different polymorphisms and include previously identified and novel mutations described in the text. The last three columns show nsSNPs in the RNA polymerase genes, rpoABC, excluding those shown in the RRDR. The genotypes illustrated are provided in full in Supplementary Table 4.
Figure 4
Figure 4. Prevalence of drug resistance mutations and association with lineage
The proportion of isolates harboring polymorphisms at each drug resistance locus was categorized by lineage. Asterisks indicate significant differences between lineages (Supplementary Table 7). Data is based on the polymorphisms detailed in Supplementary Table 4.
Figure 5
Figure 5. Distribution of rifampicin resistance and compensatory amino acid substitutions in the RNA polymerase genes, rpoBCA
Resistance mutations are clustered in the RRDR region of rpoB. All other substitutions depicted are putative compensatory mutations that co-occurred with rpoB S450L.
Figure 6
Figure 6. Transmissibility of drug resistance genotypes
The number of isolates within clusters sharing a genotypic marker was estimated by maximum likelihood reconstruction of the polymorphisms onto the phylogeny. A cluster size of one suggests acquired resistance while larger clusters are indicative of primary transmitted resistance.

Similar articles

Cited by

References

    1. World Health Organisation Global tuberculosis report. 2012
    1. Gandhi NR, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375:1830–1843. - PubMed
    1. Balabanova Y, et al. Survival of civilian and prisoner drug-sensitive, multi- and extensive drug-resistant tuberculosis cohorts prospectively followed in Russia. PLoS ONE. 2011;6:e20531. - PMC - PubMed
    1. Balabanova Y, et al. Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study. BMJ Open. 1:2011. - PMC - PubMed
    1. London Health Protection Agency Tuberculosis in the UK: annual report on tuberculosis surveillance in the UK. 2012

Publication types

MeSH terms

Substances